Controversies in the management of adenocarcinoma of the esophagus and esophagogastric junction
- 31 July 1994
- journal article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 4 (3) , 170-178
- https://doi.org/10.1016/s1053-4296(05)80065-7
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junctionGastroenterology, 1993
- Barrett's oesophagus: Effect of antireflux surgery on symptom control and development of complicationsBritish Journal of Surgery, 1992
- Cigarette and alcohol use in patients with adenocarcinoma of the gastric cardia or lower esophagusCancer, 1992
- Barrett's Esophagus and Esophageal AdenocarcinomaGastroenterology Clinics of North America, 1991
- Barrett Esophagus after Chemotherapy with Cyclophosphamide, Methotrexate, and 5-Fluorouracil (CMF): An Iatrogenic Injury?Annals of Internal Medicine, 1991
- Adenocarcinoma of the esophagus and esophguo-gastric junction: The effects of single and combined modalities on the survival and patterns of failure following treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Barrett's esophagus in scleroderma: Increased prevalence and radiographic findingsGastrointestinal Radiology, 1988
- Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Primary adenocarcinoma of the esophagusCancer, 1968
- Cancer of the EsophagusArchives of Surgery, 1955